BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 21660927)

  • 1. Progressive conduction disturbance in myotonic dystrophy.
    Palazzolo J; Trucco E; Arce M; Riera AR; Femenía F
    Cardiol J; 2011; 18(3):322-5. PubMed ID: 21660927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myotonic dystrophy - a new insight into a well-known disease].
    Lusakowska A; Sułek-Piatkowska A
    Neurol Neurochir Pol; 2010; 44(3):264-76. PubMed ID: 20625963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heart and cardiac pacing in Steinert disease.
    Nigro G; Papa AA; Politano L
    Acta Myol; 2012 Oct; 31(2):110-6. PubMed ID: 23097601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic dystrophies.
    Huang CC; Kuo HC
    Chang Gung Med J; 2005 Aug; 28(8):517-26. PubMed ID: 16265841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased temporal dispersion of myocardial repolarization in myotonic dystrophy type 1: beyond the cardiac conduction system.
    Magrì D; Piccirillo G; Bucci E; Pignatelli G; Cauti FM; Morino S; Latino P; Santini D; Marrara F; Volpe M; Antonini G; Testa M
    Int J Cardiol; 2012 May; 156(3):259-64. PubMed ID: 21112106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular pathways to myotonic dystrophy].
    Ishiura S
    Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardiac, respiratory and sleep disorders in patients with myotonic dystrophy].
    Banach M; Rakowicz M; Antczak J; Rola R; Witkowski G; Waliniowska E
    Przegl Lek; 2009; 66(12):1065-8. PubMed ID: 20514907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Myotonic dystrophy].
    Nanba E
    Nihon Rinsho; 2005 Mar; 63(3):429-33. PubMed ID: 15773341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II.
    Ha AH; Tarnopolsky MA; Bergstra TG; Nair GM; Al-Qubbany A; Healey JS
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1262-9. PubMed ID: 22385162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and molecular aspects of the myotonic dystrophies: a review.
    Machuca-Tzili L; Brook D; Hilton-Jones D
    Muscle Nerve; 2005 Jul; 32(1):1-18. PubMed ID: 15770660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular manifestations of myotonic dystrophy-1.
    Sovari AA; Bodine CK; Farokhi F
    Cardiol Rev; 2007; 15(4):191-4. PubMed ID: 17575483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.
    Liquori CL; Ricker K; Moseley ML; Jacobsen JF; Kress W; Naylor SL; Day JW; Ranum LP
    Science; 2001 Aug; 293(5531):864-7. PubMed ID: 11486088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotonic dystrophy types 1 and 2.
    Ashizawa T; Sarkar PS
    Handb Clin Neurol; 2011; 101():193-237. PubMed ID: 21496635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myotonic dystrophies type 1 and 2: a summary on current aspects.
    Schara U; Schoser BG
    Semin Pediatr Neurol; 2006 Jun; 13(2):71-9. PubMed ID: 17027856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insufficiency of electrocardiogram alone in predicting infrahisian abnormalities in patients with type 1 myotonic dystrophy.
    Siméon E; Patier-Dussauge A; Bernard-Brunet A; Clémenty N; Gouraud JB; Guyomarch B; Magot A; Probst V; Babuty D
    Int J Cardiol; 2014 Apr; 172(3):625-7. PubMed ID: 24560399
    [No Abstract]   [Full Text] [Related]  

  • 17. RNA pathogenesis of the myotonic dystrophies.
    Day JW; Ranum LP
    Neuromuscul Disord; 2005 Jan; 15(1):5-16. PubMed ID: 15639115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
    Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
    Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of mexiletine effect on conduction delay and bradyarrhythmic complications in patients with myotonic dystrophy type 1 over long-term follow-up.
    Vio R; Zorzi A; Bello L; Bozzoni V; Botta A; Rivezzi F; Leoni L; Migliore F; Bertaglia E; Iliceto S; Pegoraro E; Corrado D; Calore C
    Heart Rhythm; 2020 Nov; 17(11):1944-1950. PubMed ID: 32525073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac involvement and CTG expansion in myotonic dystrophy.
    Merlevede K; Vermander D; Theys P; Legius E; Ector H; Robberecht W
    J Neurol; 2002 Jun; 249(6):693-8. PubMed ID: 12111301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.